Shares

5 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2022

Aug 15, 2022

BUY
$0.81 - $2.53 $9,020 - $28,174
11,136 New
11,136 $9,000
Q1 2022

May 16, 2022

SELL
$2.53 - $3.9 $32,335 - $49,845
-12,781 Closed
0 $0
Q4 2021

Feb 14, 2022

BUY
$3.27 - $6.38 $41,793 - $81,542
12,781 New
12,781 $50,000
Q1 2021

May 17, 2021

SELL
$2.51 - $6.96 $31,653 - $87,772
-12,611 Closed
0 $0
Q4 2020

Feb 16, 2021

BUY
$2.15 - $11.17 $27,113 - $140,864
12,611 New
12,611 $34,000

About 180 Life Sciences Corp.


  • Ticker ATNF
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 37,698,900
  • Market Cap $70.5M
  • Description
  • 1180 Life Sciences Corp., a clinical-stage biotechnology company, develops therapeutics for unmet medical needs in chronic pain, inflammation, fibrosis, and other inflammatory diseases. Its product development platforms include fibrosis and anti-tumor necrosis factor (anti-TNF) platform, which is under Phase IIb clinical trials that focuses on f...
More about ATNF
Track This Portfolio

Track Two Sigma Securities, LLC Portfolio

Follow Two Sigma Securities, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Two Sigma Securities, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Two Sigma Securities, LLC with notifications on news.